Latest News
& Press Releases
Browse the latest news from BioSpace, and press releases from around the industry. Want to filter by date, keyword, and more? Search here.
TOP STORIES
The companies will harness the power of machine learning to increase the scalability of medicines based on spirulina, a type of blue-green algae.
The settlement is a huge development for the class action lawsuit against Takeda, which has been going on since 2016.
Moderna will construct a manufacturing facility in Canada to provide direct access to mRNA vaccines for the COVID-19 pandemic and future viral threats and respiratory viruses.
AbbVie’s Allergan Aesthetics announced it was buying Soliton in a deal worth about $550 million. Now, the Federal Trade Commission has requested additional information about the deal.
Check out where the money went in the life sciences industry this week.
Inflammation is an important protective mechanism if it can be controlled. This is a key component of Genti’s engineering and the secret to the potency of its Tregs.
On Monday, BioNTech announced revenues of €5.308 billion (about $6.2 billion) for the quarter.
The Cambridge, Mass.-based company announced that industry veteran Grant Bogle has taken over as president and CEO.
As the Delta variant rages on and COVID-19 vaccines move closer to receiving full regulatory approval, many companies across the U.S. and abroad are beginning to mandate their employees get the jab or get the boot.
Pfizer has made a deal with the small Locust Valley, New York-based company to manufacture and market the drug.
Months after landing a massive SPAC deal that carried Ginkgo Bioworks to the Nasdaq, the company is now touting a manufacturing breakthrough from partner Aldevron for mRNA vaccine components.
Visus Therapeutics has acquired an additional $20 million in funding to support its mission of developing innovative ophthalmic therapies for people worldwide.